Form 4: Surmodics Director Exercises Stock Options and Sells Shares

Surmodics director Susan E. Knight exercised stock options and sold shares on January 24, 2025.

Summary

• Director Susan E. Knight exercised stock options to acquire 7,358 shares of Surmodics common stock at a price of $27.30 per share on January 24, 2025.
• Following the exercise of options, Ms. Knight sold 5,266 shares at a price of $38.15 per share on the same day.
• After these transactions, Ms. Knight directly owns 37,240 shares of Surmodics common stock.
• Ms. Knight also holds 17,286 restricted stock units (RSUs) that will vest and be settled in shares upon the end of her service as a director.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to insider transactions, and does not indicate any positive or negative sentiment.

Industry Context

This is a routine filing related to insider transactions and is common for directors and officers of publicly traded companies. It does not indicate any specific trend in the medical device industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders, such as directors and officers.
• The transactions are typical for directors who receive stock options as part of their compensation.
• The exercise and sale of shares are within the normal range of insider trading activity.

Stakeholder Impact

• The transactions may have a minor impact on the stock price due to the sale of shares by a director.

Key Dates

Keywords

Surmodics, Director, Stock Options, Share Sale, Form 4, Insider Trading, Equity Securities, Restricted Stock Units